GENEONE DIAGNOSTICS CORPORATION
GeneOne Diagnostics Corporation recruited top R&D talents with diverse expertise worldwide. Boosted by the parent company’s many years’ experience in developing molecular biological reagents, Geneone completed the development of COVID-19 (Corona Virus Disease 2019) nucleic acid diagnostic reagent (GeneOne COVID-19 Nucleic Acid Diagnostic Kit) within a short time frame. Both CE registration and FDA EUA submission have been completed for this product. This kit excels traditional nucleic acid detection reagents in speed. Unlike traditional nucleic acid testing, which usually takes about two hours, GeneOne COVID-19 Nucleic Acid Diagnostic Kit reports test results within 45-60 minutes, while maintaining similar sensitivity and accuracy to products of well-known brands in the U.S. and Europe. GeneOne Diagnostics Corporation has the manufacturing capacity of more than one million tests per month, and look forward to contributing to fighting the epidemic.
GeneOne Specimen transport system
1.Stabilize nucleic acid before performing nucleic acid's extraction. 2.Preserves RNA at ambient temperatures without degradation. 3.Non- toxic and Eco-friendly.
Fast One step One tube DNA extraction
GeneOne AIV Nucleic Acid Diagnostic Kit
High sensitivity Easy to use Affordable price Portable
G1 Dengue Nucleic Acid Diagnostic Kit
The G 1 Dengue Nucleic Acid Diagnostic Kit is an in vitro diagnostic test, based on RT PCR and real time PCR technology, for the qualitative detection of dengue virus specific RNA This test can detect all serotypes (DENV 1 4 but does not distinguish between them
COVID 19 Nuc leic Acid Diagnostic Kit
Time Saving Highly Sensitive Highly Specificity